Jansen E, Bockstal V, Herschke F, Olsson Gisleskog P, et al. Characterization of the VHH-Fc construct rimteravimab in healthy adults and patients hospitalized for mild-to-moderate COVID-19: Two Phase 1 randomized clinical trials. PLoS Med 2026;23:e1004609.
PMID: 42213671